James M. Mock - Apr 4, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ James Dillon, As Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Apr 4, 2025
Transactions value $
-$18,088
Form type
4
Date filed
4/7/2025, 04:18 PM
Previous filing
Mar 3, 2025
Next filing
May 29, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +1.45K +9.76% 16.3K Apr 4, 2025 Direct F1
transaction MRNA Common Stock Tax liability -$18.1K -703 -4.31% $25.73 15.6K Apr 4, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -1.45K -14.28% $0.00 8.72K Apr 4, 2025 Common Stock 1.45K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of performance stock stock units.
F3 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.